Clinical Trial Details
EORTC-1508-GCG
Back to Clinical Trials Database
A phase II study of the anti-PD-L1 antibody atezolizumab, bevacizumab and acetylsalicylic acid to investigate safety and efficacy of this combination in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinoma
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 21-Dec-2016 Date Step1 close: 11-Mar-2020 Date Step2 close: 11-Mar-2020 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized blind |
Targeted Sample size | EORTC Groups: 160 - All Groups: 160 |
Treatment |
Drug Bevacizumab, Atezolizumab, Acetylsalicylic acid, Acetylsalicylic acid / placebo |
Study Staff |
Susana Banerjee (Study Coordinator) , Royal Marsden Hospital - Chelsea, London, London George Coukos (Study Coordinator) , Centre Hospitalier Universitaire Vaudois - Lausanne, Lausanne Jose Casas (TR Scientist) , EORTC Headquarters, Brussels Corneel Coens (Statistician) , EORTC Headquarters, Brussels Ilse Coppens (Clinical Operations Assistant) , EORTC Headquarters, Brussels Ruxandra Dionisie (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels Sara Meloen (Pharmacovigilance Manager) , EORTC Headquarters, Brussels David Ndah Aki (Clinical Operations Manager) , EORTC Headquarters, Brussels Gilles Sarlet (Regulatory Affairs Manager) , EORTC Headquarters, Brussels Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels Egle Venslovaite (Project Manager) , EORTC Headquarters, Brussels |
Type of cancer |
Fallopian Tube Ovarian |
Participating groups | EORTC Gynecological Cancer Group |
Recruiting centers |
APHP Centre - Univ de Paris Cite - Hoptial Europeen Georges Pompidou (PARIS, France) Centre Hospitalier Prive Saint-Gregoire (Saint-Gregoire, France) Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland) Clinique Pasteur-Lanroze (BREST, France) Guy s and St Thomas' NHS - Guy's Hospital (London, United Kingdom) Hospital Universitario San Carlos (Madrid, Spain) ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain) Leiden University Medical Centre (Leiden, Netherlands) Radboud University Medical Center Nijmegen (Nijmegen, Netherlands) Royal Marsden Hospital - Chelsea, London (London, United Kingdom) Royal Marsden Hospital - Sutton, Surrey (Surrey, United Kingdom) |
Protocol summary | http://clinicaltrials.gov/study/NCT02659384 |
NCT number | NCT02659384 |
EudraCT | 2015-004601-17 |
Financial Support | Educational Grant |